Dr David Craig
Work address Contact details
Department of Geriatric Medicine Secretary 02890 97 2153
Queen’s University of Belfast
Whitla Medical Building Office Fax 02890 32 5839
97 Lisburn Road Email david.craig@qub.ac.uk
BT9 7BL
Qualifications
FRCP (Glasgow, 2006), MD (Belfast, 2004), MPhil (Cantab, 1991), BSc 1st Class Hons (Belfast, 1990)
Present Post
Clinical Senior Lecturer Department of Geriatric Medicine Queen’s
University Belfast and Consultant Physician in Care of the Elderly Belfast
City Hospital July 2005 - present
Publications (10 most recent)
The interleukin 1B gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia. Annals of Neurology 2004; 56: 121.
Rivastigmine for vascular cognitive impairment. Cochrane Database Systematic Reviews 2005 Apr 18;(2):CD004744.
Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 2005;19:154.
A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. American Journal of Geriatric Psychiatry, 2005;13(6):460.
Book Clinical Management of the Elderly Person in Pain. McCleane and Smith editors. The Haworth Medical Press 2006 “Pain Management and Pharmacological Differences in the Elderly Patient”.
Genetically increased risk of sleep disruption in Alzheimer’s disease. Sleep 2006;29:1003.
Galantamine for Vascular Cognitive Impairment. Cochrane Database of Systematic Reviews, 2006 Jan 25.
Healthcare Technologies For Older People: What Do Physicians Think? Assistive Technology Research Series p331-334 Volume 19, 2006
Smart Homes and Beyond - ICOST2006 4th International Conference On Smart homes and health Telematics Edited by Chris Nugent, Juan Carlos Augusto
Intelligent Person-Centric Services for Smart Environments: 'Where are you?' Assistive Technology Research Series p141-148 Volume 19, 2006 Smart Homes and Beyond - ICOST2006 4th International Conference On Smart homes and health Telematics Edited by Chris Nugent, Juan Carlos Augusto
Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 11; [Epub ahead of print]
Funding awards
1990. 3 years. Department of Education for Northern Ireland: £37500. Investigation into transcriptional regulation in picornaviridae (applicant).
1990. 3 years. Emmanuel College Cambridge University Research Fellowship: £400 (applicant).
1999. 5 Years. Ulster Garden Villages Research Grant sponsored Clinical Lecturership: £130,000. The genetic determinants of non-cognitive symptomatology in Alzheimer’s disease.
2000. Senior Registrar Start-Up Grant; British Geriatrics Society: £1000. The genetic determinants of non-cognitive symptomatology in Alzheimer’s disease (applicant).
2000. 2 Years. Cochrane Fellowship, Research and Development Office/Health Research Board: £4200. Rivastigmine for Vascular Cognitive Impairment; Galantamine for Vascular Cognitive Impairment (applicant).
2005. 1 Year. Research and Development Bursary: £800. Behavioural and Psychological Symptoms of Dementia (co-applicant).
2006. 2 years. Royal College of Physicians/Dunhill trust: £110,000. Complement Factor H in Alzheimer’s disease and Macular degeneration (co-applicant)
2006. 3 years. EU Framework Programme 6: 2.6m euro. COGKNOW. Helping people with dementia manage their day (co-applicant).
2006. 3 years. Alzheimer’s Association: $192,000. Cell phone video streaming in Alzheimer’s disease (lead applicant).
2006. 1 year. Alzheimer’s Research Trust: £56,018. Haplotyping of the angiotensin-converting enzyme (ACE) and insulin-degrading enzyme (IDE) genes in Alzheimer's disease (AD); a replication study (co-applicant).
2006. 3 years. NHS R&D Office N Ireland: £465,000. The development and evaluation of a mobile phone-based video streaming (MPVS) system in providing home-support for patients with early Alzheimer’s disease (lead-applicant).